X4 Pharmaceuticals, Inc (XFOR) — DEF 14A Filings
All DEF 14A filings from X4 Pharmaceuticals, Inc. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
X4 Pharma Files DEF 14A: Executive Comp & Governance
— Apr 25, 2025 Risk: medium
X4 Pharmaceuticals, Inc. filed a DEF 14A on April 25, 2025, detailing executive compensation and corporate governance matters. The filing covers the fiscal year -
X4 Pharmaceuticals Files Definitive Proxy Statement
— Mar 24, 2025 Risk: low
X4 Pharmaceuticals, Inc. filed a definitive proxy statement (DEF 14A) on March 24, 2025, for its annual meeting. The company, formerly known as Arsanis, Inc., i
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX